DNA X, Inc. Altman Z-Score
SONM|Modified Z-Score (book value) based on FY2024 data
DNA X, Inc.'s Altman Z-Score of 2.72 places the company in the "grey zone" (1.23–2.9). This range has historically shown mixed outcomes in the Altman model (FY2024).
Based on SEC 10-K filings.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Grey Zone (1.23 - 2.9)
Grey zone - moderate risk, requires monitoring
The Altman Z-Score predicts bankruptcy risk using 5 financial ratios. Learn more
Components: book value of equity, working capital, retained earnings, EBIT, and revenue-to-assets — all derived from SEC FY2024 10-K filings.
5-Factor Decomposition
| Component | Ratio | Weight | Contribution |
|---|---|---|---|
| Working Capital / Total Assets | -0.291 | 0.717 | -0.209 |
| Retained Earnings / Total Assets | - | 0.847 | - |
| EBIT / Total Assets | 0.013 | 3.107 | 0.040 |
| Book Equity / Total Liabilities | 1.288 | 0.420 | 0.541 |
| Revenue / Total Assets | 2.356 | 0.998 | 2.351 |
| Total Z-Score | 2.72 | ||
As of FY2024 · SEC 10-K · Updated Jun 28, 2026
Z-Score Zones
Safe Zone - Company is in strong financial health with low bankruptcy risk.
Grey Zone - Uncertain financial position. Requires closer monitoring.
Distress Zone - Elevated probability of financial difficulties.